Kilitch Drugs India Ltd Q2 FY2022 consolidated net profit higher at Rs. 2.15 crore

The Board of Directors of Kilitch Drugs (India) Limited, at its meeting held today have approved the unaudited Consolidated financial results of the company for the period ended September 30, 2021.

For the quarter ended September 30, 2021(Q2 FY2022), the company's total income was ₹ 23.7386 crore, against ₹18.4941 crore in the corresponding quarter of the previous year (YoY) and ₹20.6787 crore in previous quarter (QoQ).

For the quarter ended September 30, 2021(Q2 FY2022), the company's net profit / (loss) was ₹2.1565 crore, against ₹2.0817 crore in the corresponding quarter of the previous year (YoY) and ₹1.1877 crore in previous quarter (QoQ).

For the quarter ended September 30, 2021(Q2 FY2022), the company's Earnings Per Share (EPS) was ₹1.39, against ₹1.34 in the corresponding quarter of the previous year (YoY) and ₹0.76 in previous quarter (QoQ).

Financials	Q2 FY2022	Q1 FY2022	QoQ % Change	Q2 FY2021	YoY % Change
Total Income	₹ 23.7386 crs	₹20.6787 crs	14.80%	₹18.4941 crs	28.36%
Net Profit	₹2.1565 crs	₹1.1877 crs	81.57%	₹2.0817 crs	3.59 %
EPS	₹1.39	₹0.76	82.89%	₹1.34	3.73%

For the 6 Months period ended September 30, 2021(Half Year Ended FY 2022), the company's total income was ₹44.4173 crore, against ₹29.0553 crore in the previous year (YoY) (Half Year Ended FY 2021).

The net profit / (loss) was at ₹3.3442 crore for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), compared to ₹0.7480 crore in the previous year (YoY) (Half Year Ended FY 2021).

The Earnings Per Share stood at ₹2.15 for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), against ₹0.48 in the previous year (YoY) (Half Year Ended FY 2021).

Financials	Half Year Ended FY2022	Half Year Ended FY2021	% Change
Total Income	₹44.4173 crs	₹29.0553 crs	52.87%
Net Profit	₹3.3442 crs	₹0.7480 crs	347.09%
EPS	₹2.15	₹0.48	347.92%

Shares of Kilitch Drugs (India) Limited was last trading in BSE at Rs. 157.20 as compared to the previous close of Rs. 165.30. The total number of shares traded during the day was 1483 in over 98 trades.

The stock hit an intraday high of Rs. 164.80 and intraday low of 157.05. The net turnover during the day was Rs. 235276.00.

Source : Equity Bulls

Keywords

KilitchDrugsIndia Q2FY22 H1FY22 ResultUpdate